#VELA Vela Technologies PLC investee co. #KNB Kanabo Group PLC – Treat It Launch: Online Medicinal Cannabis Clinic March 13, 2023 – Posted in: Vela Technologies Plc (VELA)

Kanabo Group plc (LSE: KNB), a patient-focused Healthtech company, has launched Treat It , a new online medicinal cannabis clinic for pain management. The new clinic aims to address the issue of limited access to pain management treatments for the approximately 8 million chronic pain sufferers in the UK. These individuals face difficulties accessing medical treatments due to long waiting times, bureaucracy, and affordability. According to recent data, 24% of chronic pain sufferers in the UK are…

#ORPH Open Orphan – Appointment of Nominated Adviser and Joint Broker April 28, 2022 – Posted in: Blog, Open Orphan (ORPH)

Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that further to the announcements by Arden Partners Plc on 11 and 14 April 2022 regarding the loss of its Nominated Adviser status upon the completion of its recommended takeover, the Company has appointed Liberum Capital Limited (“Liberum”) as its Nominated Adviser and Joint Broker. Given the…

#ORPH Open Orphan PLC – Positive results from RSV Human Challenge Study February 17, 2022 – Posted in: Blog, Open Orphan (ORPH)

Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, notes the announcement dated February 17 2022 from Enanta Pharmaceuticals, Inc . (NASDAQ: ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, on positive results from a human challenge study assessing its respiratory syncytial virus (“RSV”) antiviral candidate, EDP-938. The results…

#POLB Poolbeg Pharma – Confirmation of vaccine platform licence execution January 31, 2022 – Posted in: Blog, Poolbeg Pharma (POLB)

31 January, 2022 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’) a clinical stage infectious disease pharmaceutical company with a capital light clinical model, confirms that it has signed the licence to AnaBio Technologies’ (‘AnaBio’) microencapsulation and nanoencapsulation technologies to develop an oral vaccine delivery platform. This follows the binding term sheet announced on 16 December 2021. This licence provides Poolbeg with exclusive access to AnaBio’s microencapsulation and nanoencapsulation technologies for use in the…

#POLB Poolbeg Pharma – Poolbeg to develop oral vaccine delivery platform December 16, 2021 – Posted in: Blog, Poolbeg Pharma (POLB)

16 December, 2021- Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’) a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has signed a binding term sheet, encompassing all commercial terms, with AnaBio Technologies (AnaBio), with a full licence and collaboration agreement to follow. The partnership allows Poolbeg exclusive access to AnaBio’s microencapsulation and nanoencapsulation technologies, IP and expertise for oral vaccine applications. Poolbeg will utilise this technology in conjunction with its own expertise in…

#ORPH Open Orphan – Inside the quarantine lab where Irish company infects humans with Covid October 18, 2021 – Posted in: Blog, Open Orphan (ORPH)

Step into the foyer of the Whitechapel Hotel in London and it seems no different from any other business. But venture further in, and it becomes clear that something very strange is going on in this former textile factory. Biohazard signs on each floor warn observers not to enter. Next to the double beds in the bright and modern en-suite rooms are white trolleys containing swabs, vials, gloves and other medical paraphernalia. Peepholes on…

#VELA Vela Technologies PLC investee co. #KNB Kanabo Group PLC – Treat It Launch: Online Medicinal Cannabis Clinic March 13, 2023 – Posted in: Vela Technologies Plc (VELA)

#ORPH Open Orphan – Appointment of Nominated Adviser and Joint Broker April 28, 2022 – Posted in: Blog, Open Orphan (ORPH)

#ORPH Open Orphan PLC – Positive results from RSV Human Challenge Study February 17, 2022 – Posted in: Blog, Open Orphan (ORPH)

#POLB Poolbeg Pharma – Confirmation of vaccine platform licence execution January 31, 2022 – Posted in: Blog, Poolbeg Pharma (POLB)

#POLB Poolbeg Pharma – Poolbeg to develop oral vaccine delivery platform December 16, 2021 – Posted in: Blog, Poolbeg Pharma (POLB)

#ORPH Open Orphan – Inside the quarantine lab where Irish company infects humans with Covid October 18, 2021 – Posted in: Blog, Open Orphan (ORPH)

Address

Contact

Social

LEGAL